Inflarx NV (IFRX) PT Raised to $64 at BMO Capital Following Positive Physician Feedback

April 24, 2019 7:26 AM EDT

Send to a Friend

BMO Capital analyst Matthew Luchini raised the price target on Inflarx NV (NASDAQ: IFRX) to $64.00 (from $45.00) while maintaining …

This is a premium only article. To continue reading this article and more like it please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *